These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Interaction of ganglioside G Gtet1 and its derivatives with choleragen. Staerk J; Ronneberger J; Wiegandt H; Ziegler W Eur J Biochem; 1974 Oct; 48(1):103-10. PubMed ID: 4448163 [No Abstract] [Full Text] [Related]
85. The interaction between gangliosides and interferon. Vengris VE; Fernie BF; Pitha PM Adv Exp Med Biol; 1980; 125():479-86. PubMed ID: 7361624 [No Abstract] [Full Text] [Related]
86. Choleragen-induced cyclic nucleotide response in a lower eukaryote. Daniel JW; Oleinick NL; Whistler S FEBS Lett; 1980 Dec; 122(1):138-42. PubMed ID: 6260527 [No Abstract] [Full Text] [Related]
87. Chemical structure of monosialoganglioside GM1b biosynthesized in vitro. Stoffyn A; Stoffyn P; Yip MC Biochim Biophys Acta; 1975 Oct; 409(1):97-103. PubMed ID: 1182195 [TBL] [Abstract][Full Text] [Related]
88. Molecular interactions between micellar polysialogangliosides and affinity-purified tetanotoxins in aqueous solution. Lazarovici P; Yanai P; Yavin E J Biol Chem; 1987 Feb; 262(6):2645-51. PubMed ID: 3818615 [TBL] [Abstract][Full Text] [Related]
89. Morphological and biochemical effects of gangliosides in neuroblastoma cells. Leon A; Facci L; Benvegnù D; Toffano G Dev Neurosci; 1982; 5(1):108-14. PubMed ID: 6286268 [No Abstract] [Full Text] [Related]
90. Immunomodulatory regulation by heat-labile enterotoxins and potential therapeutic applications. Knapp MA; Johnson TA; Ritter MK; Rainer RO; Fiester SE; Grier JT; Connell TD; Arce S Expert Rev Vaccines; 2021 Aug; 20(8):975-987. PubMed ID: 34148503 [No Abstract] [Full Text] [Related]
91. Some inhibitors of the effect of cholera toxin on HeLa cells. Davies J; Tyrrell DA; Ramsden DB; Louis LN; Milne RG Exp Mol Pathol; 1973 Feb; 18(1):1-9. PubMed ID: 4120929 [No Abstract] [Full Text] [Related]
92. A 'litmus test' for molecular recognition using artificial membranes. Charych D; Cheng Q; Reichert A; Kuziemko G; Stroh M; Nagy JO; Spevak W; Stevens RC Chem Biol; 1996 Feb; 3(2):113-20. PubMed ID: 8807836 [TBL] [Abstract][Full Text] [Related]
94. Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine. Teneberg S; Hirst TR; Angström J; Karlsson KA Glycoconj J; 1994 Dec; 11(6):533-40. PubMed ID: 7696856 [TBL] [Abstract][Full Text] [Related]
95. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Holmgren J; Fredman P; Lindblad M; Svennerholm AM; Svennerholm L Infect Immun; 1982 Nov; 38(2):424-33. PubMed ID: 7141703 [TBL] [Abstract][Full Text] [Related]
96. Subunit number and arrangement in Escherichia coli heat-labile enterotoxin. Gill DM; Clements JD; Robertson DC; Finkelstein RA Infect Immun; 1981 Sep; 33(3):677-82. PubMed ID: 7026442 [TBL] [Abstract][Full Text] [Related]
97. Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin. Klipstein FA; Engert RF Infect Immun; 1981 Jan; 31(1):144-50. PubMed ID: 7011990 [TBL] [Abstract][Full Text] [Related]
98. Role of membrane gangliosides in the binding and action of bacterial toxins. Fishman PH J Membr Biol; 1982; 69(2):85-97. PubMed ID: 6752418 [TBL] [Abstract][Full Text] [Related]